These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2242067)

  • 1. Dermal mast cell degranulation in systemic sclerosis.
    Seibold JR; Giorno RC; Claman HN
    Arthritis Rheum; 1990 Nov; 33(11):1702-9. PubMed ID: 2242067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?
    Hawkins RA; Claman HN; Clark RA; Steigerwald JC
    Ann Intern Med; 1985 Feb; 102(2):182-6. PubMed ID: 3966756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation.
    Akimoto S; Ishikawa O; Igarashi Y; Kurosawa M; Miyachi Y
    Br J Dermatol; 1998 Mar; 138(3):399-406. PubMed ID: 9580789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermal mast cell density in fingers reflects severity of skin sclerosis in systemic sclerosis.
    Yukawa S; Yamaoka K; Sawamukai N; Shimajiri S; Kubo S; Miyagawa I; Sonomoto K; Saito K; Tanaka Y
    Mod Rheumatol; 2013 Nov; 23(6):1151-7. PubMed ID: 23271169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell changes in a case of rapidly progressive scleroderma-ultrastructural analysis.
    Claman HN
    J Invest Dermatol; 1989 Feb; 92(2):290-5. PubMed ID: 2918235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
    J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic dysfunction in scleroderma: evidence for increased mast cell releasability and HLA-DR positivity in the dermis.
    Pearson ME; Huff JC; Giorno RC; Panicheewa S; Claman HN; Steigerwald JC
    Arthritis Rheum; 1988 May; 31(5):672-7. PubMed ID: 2454120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis complicated with localized scleroderma-like lesions induced by Köbner phenomenon.
    Saigusa R; Asano Y; Yamashita T; Takahashi T; Nakamura K; Miura S; Ichimura Y; Toyama T; Taniguchi T; Sumida H; Tamaki Z; Miyazaki M; Yoshizaki A; Sato S
    J Dermatol Sci; 2018 Mar; 89(3):282-289. PubMed ID: 29279288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation.
    Irani AM; Gruber BL; Kaufman LD; Kahaleh MB; Schwartz LB
    Arthritis Rheum; 1992 Aug; 35(8):933-9. PubMed ID: 1642658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketotifen-induced remission in progressive early diffuse scleroderma: evidence for the role of mast cells in disease pathogenesis.
    Gruber BL; Kaufman LD
    Am J Med; 1990 Sep; 89(3):392-5. PubMed ID: 2393046
    [No Abstract]   [Full Text] [Related]  

  • 11. Mast cells and their degranulation in the Tsk mouse model of scleroderma.
    Walker M; Harley R; Maize J; DeLustro F; LeRoy EC
    Proc Soc Exp Biol Med; 1985 Nov; 180(2):323-8. PubMed ID: 4048170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells are a source of transforming growth factor β in systemic sclerosis.
    Hügle T; Hogan V; White KE; van Laar JM
    Arthritis Rheum; 2011 Mar; 63(3):795-9. PubMed ID: 21360509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression.
    Bosello S; Angelucci C; Lama G; Alivernini S; Proietti G; Tolusso B; Sica G; Gremese E; Ferraccioli G
    Arthritis Res Ther; 2018 Apr; 20(1):75. PubMed ID: 29669578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects.
    Pesci A; Foresi A; Bertorelli G; Chetta A; Olivieri D
    Am Rev Respir Dis; 1993 Mar; 147(3):684-9. PubMed ID: 7680188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib stimulates human skin type mast cell degranulation and maturation.
    Mizukami Y; Sugawara K; Kira Y; Tsuruta D
    J Dermatol Sci; 2017 Dec; 88(3):308-319. PubMed ID: 28843624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased pigmentation in scleroderma.
    Pope JE; Shum DT; Gottschalk R; Stevens A; McManus R
    J Rheumatol; 1996 Nov; 23(11):1912-6. PubMed ID: 8923365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy is a key feature in the pathogenesis of systemic sclerosis.
    Frech T; De Domenico I; Murtaugh MA; Revelo MP; Li DY; Sawitzke AD; Drakos S
    Rheumatol Int; 2014 Mar; 34(3):435-9. PubMed ID: 23934520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor and mast cell distribution in the skin of patients with systemic sclerosis.
    Tuveri MA; Passiu G; Mathieu A; Aloe L
    Clin Exp Rheumatol; 1993; 11(3):319-22. PubMed ID: 8353988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural analysis of human skin biopsy specimens from patients receiving recombinant human stem cell factor: subcutaneous injection of rhSCF induces dermal mast cell degranulation and granulocyte recruitment at the injection site.
    Dvorak AM; Costa JJ; Monahan-Earley RA; Fox P; Galli SJ
    J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):793-806. PubMed ID: 9648707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of endothelin-1 and its binding sites in scleroderma skin.
    Vancheeswaran R; Azam A; Black C; Dashwood MR
    J Rheumatol; 1994 Jul; 21(7):1268-76. PubMed ID: 7525957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.